Literature DB >> 10458441

Reconstitution of human corporal smooth muscle and endothelial cells in vivo.

H J Park1, J J Yoo, R T Kershen, R Moreland, A Atala.   

Abstract

PURPOSE: The availability of autologous erectile tissue composed of corporal smooth muscle and endothelial cells would be beneficial in patients undergoing penile reconstruction. We previously showed that cultured cavernous cells seeded on polymer scaffolds form corporal muscle when implanted in vivo. However, to reconstruct corporal tissue endothelial and corporal muscle cells are necessary. In this study we investigated the possibility of developing tissue composed of corporal cells in vivo by combining smooth muscle and endothelial cells.
MATERIALS AND METHODS: Human corporal smooth muscle and endothelial cells were seeded on biodegradable polyglycolic acid polymer scaffolds at concentrations of 20 x 10(6) and 10 x 10(6) cells per cm3, respectively. A total of 60 polymer scaffolds seeded with cells and 20 control polymers without cells were implanted in the subcutaneous space of 20 athymic mice. Mice were sacrificed 1, 3, 5, 7, 14, 21, 28 and 42 days, respectively, after implantation. Immunocytochemical and histochemical analyses were performed with antifactor VIII, antipancytokeratins and anti-alpha actin antibodies.
RESULTS: Histologically the retrieved polymers seeded with corporal smooth muscle and endothelial cells showed the formation of multilayered smooth muscle strips adjacent to endothelial cells 7 days after implantation. Increased organization of the smooth muscle tissue and accumulation of endothelium lining the luminal structures were evident by 14 days. A well organized tissue construct was noted 28 and 42 days after implantation. There was no evidence of tissue formation in controls. Immunocytochemical analysis using antifactor VIII to identify native vasculature only and antipancytokeratins to identify ECV 304 endothelial cells only distinguished the origin of the vascular structures in each construct. Anti-alpha-actin confirmed the smooth muscle phenotype.
CONCLUSIONS: Human corporal smooth muscle and endothelial cells seeded on biodegradable polymer scaffolds formed vascularized corpus cavernosum muscle when implanted in vivo. To our knowledge this is the first demonstration in tissue engineering in which capillary formation was facilitated by the addition of endothelial cells in composite tissue in vivo.

Entities:  

Mesh:

Year:  1999        PMID: 10458441     DOI: 10.1097/00005392-199909000-00046

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  [Tissue engineering in urology. Basic principles and application].

Authors:  G Bartsch; A Atala
Journal:  Urologe A       Date:  2003-02-28       Impact factor: 0.639

Review 2.  Emerging tools for erectile dysfunction: a role for regenerative medicine.

Authors:  Lukman Hakim; Frank Van der Aa; Trinity J Bivalacqua; Petter Hedlund; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2012-07-24       Impact factor: 14.432

3.  In vivo human corpus cavernosum regeneration: fabrication of tissue-engineered corpus cavernosum in rat using the body as a natural bioreactor.

Authors:  Abdol-Mohammad Kajbafzadeh; Reza Abbasioun; Nastaran Sabetkish; Shabnam Sabetkish; Ali Akbar Habibi; Kamyar Tavakkolitabassi
Journal:  Int Urol Nephrol       Date:  2017-04-05       Impact factor: 2.370

Review 4.  Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges.

Authors:  G T Finosh; Muthu Jayabalan
Journal:  Biomatter       Date:  2012 Jan-Mar

5.  Bioengineered corporal tissue for structural and functional restoration of the penis.

Authors:  Kuo-Liang Chen; Daniel Eberli; James J Yoo; Anthony Atala
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

Review 6.  Towards clinical application of tissue engineering for erectile penile regeneration.

Authors:  Tom W Andrew; Muholan Kanapathy; Log Murugesan; Asif Muneer; Deepak Kalaskar; Anthony Atala
Journal:  Nat Rev Urol       Date:  2019-10-24       Impact factor: 14.432

Review 7.  Tissue engineering in urology: where are we going?

Authors:  Adam R Metwalli; James R Colvert; Bradley P Kropp
Journal:  Curr Urol Rep       Date:  2003-04       Impact factor: 2.862

8.  Regenerative medicine strategies for treating neurogenic bladder.

Authors:  James J Yoo; Jennifer Olson; Anthony Atala; Bupwan Kim
Journal:  Int Neurourol J       Date:  2011-09-30       Impact factor: 2.835

Review 9.  Tissue engineering of the penis.

Authors:  Manish N Patel; Anthony Atala
Journal:  ScientificWorldJournal       Date:  2011-12-29

Review 10.  Tissue engineering in urology.

Authors:  A Atala
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.